FDA Label for Orajel For Cold Sores Single Dose
View Indications, Usage & Precautions
Orajel For Cold Sores Single Dose Product Label
The following document was submitted to the FDA by the labeler of this product Church & Dwight Co., Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredients
ACTIVE INGREDIENTS
Benzalkonium chloride, 0.13%
Benzocaine, 5%
Purpose
PURPOSE
Topical Antiseptic
Uses
USES
- to treat cold sores / fever blisters
Warnings
WARNINGS
For external use only. Flammable, keep away from fire or flame.
Methemoglobinemia warning: Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray or blue colored skin (cyanosis), headache, rapid heart beat, shortness of breath, dizziness or lightheadedness, fatigue or lack of energy
Allergy alert: do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other "caine" anesthetics
Do Not Use
- in the eyes
- over large areas of the body
- if you are allergic to any ingredient in this product
- more than 3 times per day
- longer than one week unless directed by a physician
- for teething
- in children under 2 years of age
Stop Use And Ask A Dentist Or Physician If
- condition persists or worsens
- symptoms persist for more than 7 days
Ask A Physician If
- used to treat deep or puncture wounds, animal bites, or serious burns
- you are pregnant or nursing a baby
When Using This Product
You may feel a brief stinging sensation when you apply it. The sting should go away in a short time.
Keep Out Of Reach Of Children
KEEP OUT OF REACH OF CHILDREN
In case of overdose, or allergic reaction, get medical help or contact a Poison Control Center right away.
Directions
Directions
• Slide-off to remove the protective blue paper cover and slide it on the other end-opposite the white applicator tip
• Squeeze the vial firmly on the arrow shown on the blue paper cap until you hear it snap
• Hold with the white applicator tip down to allow the medication to saturate the tip
• To minimize pain during application gently touch the site of the cold sore with the saturated applicator tip. Once the area is numb, rub the site of the cold sore and the surrounding area. Rub firmly to allow the treatment to deeply penetrate the skin.
• To treat most cold sores, multiple treatments may be required
• Discard after use
• For best results ensure that lip area is free of lip preparations, lotions, ointments, residual beverages, or cosmetics, including lipstick
Adults and children over 2 years of age: Do not use this more than 3 times per day
Children between 2 year and 12 years of age: Ask a doctor before use. Should be supervised in the use of this product
Children under 2 years of age: Do not use
OTHER INFORMATION
- Store at room temperature
- The ingredients in toothpaste, soft drinks, and some fruit juices can deactivate the active ingredient in Orajel Single Dose.
- For best results, avoid brushing your teeth with toothpaste or drinking soft drinks or fruit juices for one hour after applying the drug.
- Do not use if package is torn, cut or otherwise damaged
Inactive Ingredients
INACTIVE INGREDIENTS
isopropyl alcohol (70% v/v), water
Questions Or Comments?
Questions or comments call us at 1 800 952 5080 Monday through Friday ET or visit our website at www orajel com
Principal Display Panel
Fast-Acting
Orajel™ Instant Pain Relief
Coldsore
Patented Treatment
Topical Antiseptic/
Topical Anethetic
Contains 4 treatment vials
NET 0.08 FL OZ (2.4mL) Total
* Please review the disclaimer below.